features: Sickle Cell Disease

ASH press briefing rundown: optimizing pediatric care

VJHemOnc is thrilled to bring you the latest updates from the 64th American Society of Hematology (ASH) Annual Meeting and…

ASH press briefing rundown: new drugs and targets

VJHemOnc is thrilled to bring you the latest updates from the 64th American Society of Hematology (ASH) Annual Meeting and…

Voxelotor: increased hemoglobin, reduced hemolysis markers in sickle cell disease

Voxelotor increased hemoglobin levels and reduced markers of hemolysis compared to placebo in patients with sickle cell disease, according to…